Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT01503944

A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)

Detection of Striatal Dopaminergic Degeneration and Neocortical Amyloid Pathology in Patients With Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease, and Healthy Elderly Volunteers

Sponsor: Avid Radiopharmaceuticals

Conditions Alzheimer's Disease Dementia With Lewy Bodies Parkinson's Disease

Interventions 18F-AV-133 18F-AV-45

Updated 7 times since 2017 Last updated: Aug 3, 2012 Started: Mar 31, 2010 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01503944, this PHASE1/PHASE2 trial focuses on Alzheimer's Disease and Dementia With Lewy Bodies and remains completed. Sponsored by Avid Radiopharmaceuticals, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Avid Radiopharmaceuticals

Data source: Avid Radiopharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States
• Sun City, United States